The Crohn’s & Colitis Foundation of America Chooses LWW to Expand the Readership and Reach of IBD through Print, Online and Digital Channels
New York, NY (August 27, 2012) – Wolters Kluwer Health and the Crohn’s & Colitis Foundation of America, Inc. (CCFA) announced today an agreement to publish Inflammatory Bowel Diseases. Effective with the January 2013 issue, Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, will be the journal’s publisher of record.
Inflammatory Bowel Diseases® (IBD), the official journal of the CCFA, is the first journal dedicated exclusively to IBD. The journal covers topics of interest to the professional clinician or researcher in this burgeoning field with original, peer-reviewed articles in clinical and basic science areas, as well as invited in-depth reviews of key treatment issues and groundbreaking research. IBD covers the unique and important issues in pediatric IBD, as well as articles pertaining to adult patients.
“We are delighted to be selected by the highly regarded Crohn’s & Colitis Foundation of America as the publisher of IBD journal,” said Karen Abramson, President & CEO of Wolters Kluwer Health Medical Research. “IBD is a leading journal and critical resource among gastroenterology practitioners. Our partnership with the CCFA will help them to expand the journal’s reach and impact globally, and engage new and existing CCFA members through innovative publishing solutions and strategies.”
“The CCFA chose to partner exclusively with Wolters Kluwer Health and are excited about our partnership to elevate IBD’s impact globally,” said Marjorie Merrick, Vice President of Research and Scientific Programs at the CCFA. “The LWW publishing team has taken a leadership position in innovating digital journal strategies, and we believe this is the best team to further develop and advance IBD as a leading resource accessible to our members and practitioners when and where they need access to inform clinical decisions and patient care.”
IBD is currently available for institutional access exclusively through Ovid’s medical research platform, OvidSP, used by more than 12,000 institutions globally. Ovid is part of Wolters Kluwer Health.
About CCFA
The Crohn’s & Colitis Foundation of America (CCFA) is the largest voluntary nonprofit health organization dedicated to finding cures for Inflammatory Bowel Diseases (IBD). CCFA’s mission is to cure Crohn’s disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research, providing educational resources for patients and their families, medical professionals, and the public, and furnishing supportive services for those afflicted with IBD. For more information, visit www.ccfa.org,
About Wolters Kluwer Health and Lippincott Williams & Wilkins
Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes. LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).
Contacts:
Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com
Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com